In two separate clinical trials, researchers at Albert Einstein College of Medicine of Yeshiva University have found that periodic meetings with a lactation consultant encourages women traditionally resistant to breastfeeding to do so, at least for a few months—long enough for mother and child to gain health benefits.
Researchers at Albert Einstein College of Medicine and Ferkauf Graduate School of Psychology, both affiliated with Yeshiva University, and the New York City Department of Health and Mental Hygiene (DOHMH) have been awarded a $2.5 million grant from the National Institutes of Health (NIH) to study a telephone-based approach to improving diabetes self-management and treatment outcomes in primary care.
The National Institutes of Health (NIH) has chosen two leading aging researchers at Albert Einstein College of Medicine (http://www.einstein.yu.edu/) of Yeshiva University to chair panels at the first symposium on “geroscience”—the study of how aging influences the onset of chronic diseases.
An investigational drug that disrupts tumor blood vessels shows promise against a rare type of pancreatic cancer, scientists at Albert Einstein College of Medicine of Yeshiva University have found. Their results were presented October 20 during a poster session at an international cancer conference.
Gene mutations increase as people age, which helps explain why cancer usually strikes older people. But what other consequences of aging promote cancer development or protect against it? This is one of the 24 “Provocative Questions” that the National Cancer Institute (NCI) wants researchers to address. Now, a team of scientists at Albert Einstein College of Medicine of Yeshiva University has received a $2.8 million grant from NCI to investigate this question. The researchers will examine the role of epigenetics in causing lung cancer in people of different ages.
Albert Einstein College of Medicine of Yeshiva University and Montefiore Medical Center have received a $25 million grant from the National Institutes of Health (NIH) for the Harold and Muriel Block Institute for Clinical and Translational Research (ICTR) at Einstein and Montefiore. The two institutions received their initial Clinical and Translational Science Award (CTSA) from the NIH in 2008 to launch this joint collaboration.
Our ability to detect heat, touch, tickling and other sensations depends on our sensory nerves. Now, for the first time, researchers at Albert Einstein College of Medicine of Yeshiva University have identified a gene that orchestrates the crucially important branching of nerve fibers that occurs during development. The findings were published online today in the journal Cell.
Findings from a study involving thousands of postmenopausal women suggest that women who develop invasive breast cancer may benefit from taking supplements containing both multivitamins and minerals. The new research, published today in Breast Cancer Research and Treatment, found that the risk of dying from invasive breast cancer was 30 percent lower among multivitamin/mineral users compared with nonusers.
The National Cancer Institute has awarded Albert Einstein Cancer Center at Albert Einstein College of Medicine a $16.7 million grant.
Behavioral abnormalities are traditionally thought to originate in the brain. But a new study by researchers at Albert Einstein College of Medicine of Yeshiva University has found that inner-ear dysfunction can directly cause neurological changes that increase hyperactivity.
Scientists at Albert Einstein College of Medicine of Yeshiva University have shown that high-functioning autism spectrum disorder (ASD) children appear to outgrow a critical social communication disability. Younger children with ASD have trouble integrating the auditory and visual cues associated with speech, but the researchers found that the problem clears up in adolescence. The study was published today in the online edition of the journal Cerebral Cortex.
Researchers at Albert Einstein College of Medicine of Yeshiva University have found that community-based pharmacies can be effective locations for offering rapid HIV testing, diagnosing HIV, and connecting those who test positive with medical care quickly. The study publishes online today in the August issue of the journal AIDS Patient Care and STDs.
Researchers at Albert Einstein College of Medicine of Yeshiva University have found that nerves play a critical role in both the development and spread of prostate tumors. Their findings, using both a mouse model and human prostate tissue, may lead to new ways to predict the aggressiveness of prostate cancer and to novel therapies for preventing and treating the disease. The study published online today in the July 12 edition of Science.
Today, researchers at Albert Einstein College of Medicine of Yeshiva University convened a one-day conference on Jewish genetics designed to encourage collaboration and advance the field of research. Such research could help scientists identify causes and potential treatments for population-specific diseases as well as more common disorders afflicting the general population.
Researchers at Albert Einstein College of Medicine of Yeshiva University have shown that soccer players who frequently head the ball have brain abnormalities resembling those found in patients with concussion (mild traumatic brain injury). The study, which used advanced imaging techniques and cognitive tests that assessed memory, published online today in the journal Radiology.
Philip O. Ozuah, M.D., Ph.D., will deliver the keynote address at Albert Einstein College of Medicine’s 2013 commencement ceremony.
In a striking, unexpected discovery, researchers at Albert Einstein College of Medicine of Yeshiva University have determined that vitamin C kills drug-resistant tuberculosis (TB) bacteria in laboratory culture. The finding suggests that vitamin C added to existing TB drugs could shorten TB therapy, and it highlights a new area for drug design. The study was published today in the online journal Nature Communications.
Albert Einstein College of Medicine researchers have discovered that chemo induces a type of nerve damage inside bone marrow that can cause delays in recovery after bone marrow transplantation. The findings suggest that combining chemotherapy with nerve-protecting agents may prevent long-term bone marrow injury.
Two faculty members at Albert Einstein College of Medicine of Yeshiva University have been elected to the National Academy of Sciences. Robert Singer, Ph.D., and William Jacobs, Jr., Ph.D., were among the select scientists who will be inducted into the Washington-based organization at a ceremony in April 2014.
While the search continues for the Fountain of Youth, researchers may have found the body’s “fountain of aging”: the brain region known as the hypothalamus. For the first time, scientists at Albert Einstein College of Medicine of Yeshiva University report that the hypothalamus of mice controls aging throughout the body. Their discovery of a specific age-related signaling pathway opens up new strategies for combating diseases of old age and extending lifespan. The paper was published today in the online edition of Nature.
Researchers at Albert Einstein College of Medicine of Yeshiva University have developed a therapy for pancreatic cancer that uses Listeria bacteria to selectively infect tumor cells and deliver radioisotopes into them. The experimental treatment dramatically decreased the number of metastases (cancers that have spread to other parts of the body) in a mouse model of highly aggressive pancreatic cancer without harming healthy tissue. The study was published today in the online edition of the Proceedings of the National Academy of Sciences.
Researchers at Albert Einstein College of Medicine of Yeshiva University have discovered how the protein that blocks HIV-1 from multiplying in white blood cells is regulated. HIV-1 is the virus that causes AIDS, and the discovery could lead to novel approaches for addressing HIV-1 “in hiding” – namely eliminating reservoirs of HIV-1 that persist in patients undergoing antiretroviral therapy. The study was published today in the online edition of the journal Cell Host & Microbe.
Allen M. Spiegel, M.D., the Marilyn and Stanley M. Katz Dean of Albert Einstein College of Medicine of Yeshiva University, tonight publicly announced the College of Medicine’s largest fundraising effort—a capital campaign to raise at least $500 million, known as “The Campaign to Transform Einstein.”
Albert Einstein College of Medicine of Yeshiva University will join the New York Genome Center as its twelfth Institutional Founding Member. A collaboration among leading academic medical centers, research universities and commercial organizations, NYGC aims to transform medical research and clinical care by creating one of the largest genomics research facilities in North America.
Researchers at Albert Einstein College of Medicine of Yeshiva University have discovered a novel strategy for preventing infections due to the highly common herpes simplex viruses, the microbes responsible for causing genital herpes (herpes simplex virus 2) and cold sores (herpes simplex virus 1). The finding, published online by The FASEB Journal, could lead to new drugs for treating or suppressing herpes virus infections.
Researchers at Albert Einstein College of Medicine of Yeshiva University and the Icahn School of Medicine at Mount Sinai have found that macrophages – white blood cells that play a key role in the immune response – also help to both produce and eliminate the body’s red blood cells (RBCs). The findings could lead to novel therapies for diseases or conditions in which the red blood cell production is thrown out of balance. The study, conducted in mice, is published today in the online edition of the journal Nature Medicine.
Researchers at Albert Einstein College of Medicine of Yeshiva University have been awarded a $12 million grant from the National Institutes of Health (NIH) to develop a drug-impregnated intravaginal ring to prevent HIV infection in women.
Researchers at Albert Einstein College of Medicine have discovered how the most common genetic mutations in familial Parkinson’s disease damage brain cells.
Sports-related concussion is an increasingly recognized public health problem. At least 1.6 million sports- and recreation-related traumatic brain injuries occur in the United States annually. While the primary focus has been on football, soccer has come under greater scrutiny. “Heading” in soccer may be largely safe, but in light of wide concern for repetitive mild brain injury, further investigation is required to determine if – and how much – “heading” can be done with little or no harm to the player.
John Condeelis, Ph.D., and Robert Singer, Ph.D., of Albert Einstein College of Medicine, will describe their imaging research at the AAAS Annual Meeting.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right